A Multicompartment Human Kidney Proximal Tubule-on-a-Chip Replicates Cell Polarization-Dependent Cisplatin Toxicity

Tom T G Nieskens1, Mikael Persson1, Edward J Kelly1

  • 1CVRM Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden (T.T.G.N., M.P., A.-K.S.) and Department of Pharmaceutics and Kidney Research Institute, University of Washington, Seattle, Washington (E.J.K.).

Insights

A novel kidney-on-a-chip model using human cells replicates proximal tubule function, enabling accurate prediction of drug-induced kidney injury by showing cisplatin toxicity only when administered to the basolateral side.

Area of Science:

  • Biotechnology
  • Renal Physiology
  • Drug Discovery

Background:

  • Drug-induced kidney injury (DIKI) is a significant clinical challenge and a major cause of drug attrition in pharmaceutical development.
  • Existing in vitro models often lack the physiological relevance needed to accurately predict DIKI.
  • The kidney proximal tubule is a primary site for adverse drug reactions.

Purpose of the Study:

  • To develop and validate a human kidney proximal tubule-on-a-chip model with enhanced physiological relevance for predicting DIKI.
  • To assess the polarized expression and function of key transporters in the chip model.
  • To evaluate the cell polarization-dependent toxicity of cisplatin in this advanced in vitro system.

Main Methods:

  • Human-derived renal proximal tubule epithelial cells (HRPTECs) were cultured in a dual-channel Nortis chip for 7 days to form polarized tubules.
  • The model's integrity and brush border characteristics were confirmed through protein expression and localization analysis.
  • Gene expression of key drug transporters (MATE1, MATE2-k, megalin, OCT2) was quantified.
  • Cisplatin toxicity was assessed following basolateral or apical administration, with and without the OCT2 inhibitor cimetidine.

Main Results:

  • The HRPTEC cultures in the chip exhibited characteristics of an intact proximal tubule brush border, including expression of tight junction protein 1 and primary cilia.
  • Significant upregulation of efflux transporters (MATE1, MATE2-k) and endocytosis receptor (megalin) was observed compared to 2D cultures.
  • Organic cation transporter 2 (OCT2) showed exclusive basolateral localization.
  • Basolateral cisplatin infusion induced significant toxicity (reduced cell number, compromised barrier integrity), which was abrogated by cimetidine.
  • Apical cisplatin infusion did not cause toxicity, consistent with the polarized localization of uptake transporters.

Conclusions:

  • A dual-channel human kidney proximal tubule-on-a-chip model was successfully developed, demonstrating epithelial polarization and physiological relevance.
  • The model accurately replicated cell polarization-dependent cisplatin toxicity, restricted to the basolateral membrane due to OCT2 localization.
  • This chip model offers a promising platform for improving in vitro DIKI studies in drug discovery, potentially reducing attrition rates.

Related Concept Videos